Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Cardiovascular, Blood & Acute Care
Filter     Order     Display # 
Date Item Title Hits
01 Sep 2010 Cellerant Therapeutics Awarded $153 Million Contract by Biomedical Advanced Research and Development Authority (BARDA) to Develop Treatment for Acute Radiation Syndrome (ARS) 2
31 Aug 2010 Sangart, Inc. Reports Positive Phase IIa Data for Novel Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients 2
31 Aug 2010 CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up 2
31 Aug 2010 Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study 2
31 Aug 2010 Combination Therapy of Telmisartan and Amlodipine Provides Significantly Better Blood Pressure Lowering Than Either Agent Alone 2
30 Aug 2010 Pluristem’s Placenta Derived Cells Chosen by European Commission’s Seventh Framework Program (FP7) Study for Treatment of Diastolic Heart Failure (DHF) in Type 2 Diabetic Patients 3
30 Aug 2010 Portola Pharmaceuticals Announces Presentation of New Pharmacodynamic Data From Phase 2 Trial of Investigational Factor Xa Inhibitor, Betrixaban 3
30 Aug 2010 Nanotherapeutics Submits Investigational New Drug Application to FDA for Clinical Testing of Oral Drug to Treat Radiation Exposure 3
30 Aug 2010 A new era for patients with atrial fibrillation - Dabigatran etexilate at the forefront 3
30 Aug 2010 Genetic substudy shows fewer major cardiovascular events with ticagrelor (brilinta) regardless of relevant genetic variability in ACS patients 3
30 Aug 2010 Portola Pharmaceuticals Announces That Phase 2 INNOVATE-PCI Trial With Elinogrel Achieved Objectives 3
27 Aug 2010 Novartis receives FDA approval of Tekamlo, a single-pill combination of aliskiren and amlodipine to treat high blood pressure 3
26 Aug 2010 Cardioxyl Pharmaceuticals Initiates Dose-Defining Phase IIa Study of Its Lead Candidate, CXL-1020, in Heart Failure Patients 4
26 Aug 2010 Uniplas Clinical Development Successfully Completed 3
25 Aug 2010 Actelion Pharmaceuticals Announces FDA Approval of Brand Name for Commercially Available VELETRI (epoprostenol for injection) for Pulmonary Arterial Hypertension 5
25 Aug 2010 Pharming Plans Submission Rhucin BLA To Us FDA End 2010 4
17 Aug 2010 FDA Recommends Dropping Low Blood Pressure Drug - Midodrine Hydrochloride Marketed by Shire Development Inc. 10
11 Aug 2010 PolyMedix Successfully Completes Phase 1B/2 Heparin Dose-Ranging Study with PMX-60056 Heptagonist 11
10 Aug 2010 FDA Approves 8 mg Vial of NovoSeven RT for the Treatment of Hemophilia A or B with Inhibitors and Enhanced Shelf Life for All Vial Sizes 12
10 Aug 2010 D-Pharm Receives Top-line Results From Cardiac Safety Study With DP-b99 10
09 Aug 2010 Pfizer Receives FDA Approval for Prefilled Dual-Chamber Syringe for Use in the Treatment of Hemophilia A 12
05 Aug 2010 Data from First Phase 3 Trial (EDEMA3) for KALBITOR (ecallantide) Published in The New England Journal of Medicine 12
05 Aug 2010 ViroPharma Announces Publication of Cinryze (C1 Esterase Inhibitor [Human]) Phase 3 Trial Results in Hereditary Angioedema (HAE) in the New England Journal of Medicine 12
05 Aug 2010 Bayer’s Rivaroxaban Meets Primary Endpoint in Long-Term Phase III EINSTEIN-DVT Study 19
02 Aug 2010 Cardioxyl Pharmaceuticals Announces Positive Results from First Clinical Study of its Lead Therapy, CXL-1020, in Heart Failure Patients 11
30 Jul 2010 Orexigen Therapeutics Announces Publication of COR-I Phase 3 Study of Contrave in Lancet 12
29 Jul 2010 FDA Advisory Committee Recommends Approval of AstraZeneca PLC (AZN)'s Brilinta (Ticagrelor) for Acute Coronary Syndromes; AstraZeneca Lifts Forecast Due to Ruling 13
28 Jul 2010 Trophos publishes the identification and characterization of the novel cardioprotective compound, TRO40303 19
28 Jul 2010 Athersys Announces Positive Results from Phase I Study of Multistem(R) in Heart Attack Patients 11
26 Jul 2010 FDA Approves Tribenzor, A New Three-In-One Combination Product for the Treatment of High Blood Pressure 21
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 1 - 30 of 1461

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Tau and Amyloid Beta Targeted Therapy of Alzheimer’s Disease

Order Now

Recommended Report

R&D Drug Pipeline Database
Order Now

Subscribe La Merie Biologics